Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Trials ; 6(6): 618-27, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19889888

RESUMO

BACKGROUND: Even though adverse event (AE) collection and official accounting are mandatory for clinical trials, there are limited detailed guidelines specifying how to summarize the event for reporting in a timely and expeditious manner. This article details the AE and serious adverse event (SAE) reporting summary developed for a large multi-center National Institutes of Health (NIH)-sponsored clinical trial. PURPOSE: To review and analyze the large volume of AE data reported by 10 sites (806 SAEs and 19,034 AEs from August 2000 to May 2007) the automated SAE summary was developed. It was designed to ensure timeliness and clarity in the complex process of AE review and reporting. METHODS: The AE and SAE case report forms (CRFs) as well as the automated SAE summary were developed within a database management system developed by the Data Coordinating Center (DCC) which allowed for web-based data entry at the DCC and 10 sites and offered immediate overall and site-specific reports accessible by the DCC, site, and NIH project staff. RESULTS: The automated SAE summary pulled data from multiple CRFs to create a succinct and informative summary and allowed for prompt and easy reporting to the regulatory agencies. The summary was adaptable to the needs of reviewers because of the availability of multiple search options.


Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos/organização & administração , Antivirais/efeitos adversos , Processamento Eletrônico de Dados/métodos , Hepatite C Crônica/tratamento farmacológico , Interferon-alfa/efeitos adversos , Polietilenoglicóis/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como Assunto/métodos , Antivirais/uso terapêutico , Carcinoma Hepatocelular/etiologia , Carcinoma Hepatocelular/prevenção & controle , Sistemas de Gerenciamento de Base de Dados , Progressão da Doença , Hepatite C Crônica/complicações , Hepatite C Crônica/mortalidade , Humanos , Interferon alfa-2 , Interferon-alfa/uso terapêutico , Cirrose Hepática/etiologia , Cirrose Hepática/prevenção & controle , Falência Hepática/etiologia , Falência Hepática/prevenção & controle , Neoplasias Hepáticas/etiologia , Neoplasias Hepáticas/prevenção & controle , Estudos Multicêntricos como Assunto/métodos , National Institutes of Health (U.S.) , Polietilenoglicóis/uso terapêutico , Proteínas Recombinantes , Projetos de Pesquisa , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...